A Comparison of Patient and Physician-Rated New York Heart Association Class in a Community-Based Heart Failure Clinic
Abstract
Objective
The New York Heart Association (NYHA) classification is recommended for grading symptoms of chronic heart failure and is a powerful prognostic marker. Patient-rated NYHA (Pa-NYHA) and physician-rated NYHA (Dr-NYHA) class have never been compared directly, and it is unknown whether they carry similar prognostic significance.
Methods and Results
NYHA class was rated independently by a physician and patient in 1752 patients referred with suspected heart failure. Pa-NYHA and Dr-NYHA varied by 1 class in 37.1% cases and by 2 classes in 12.8% cases. Mean Dr-NYHA and Pa-NYHA were higher in women than men (1.98 vs 1.89, P = .016; 2.17 vs 2.02, P = .002) despite less cardiac disease. Dr-NYHA correlated more with 6-minute walk test distance and severity of left ventricular systolic dysfunction than Pa-NYHA (Spearman's ρ: −0.53 vs −0.44 and 0.32 vs 0.16). Dr-NYHA better predicted mortality when compared with Pa-NYHA (log-rank: χ2 = 105 vs 46, both P < .001).
Conclusion
Patients rate NYHA differently from physicians, and women rate NYHA differently from men. Dr-NYHA relates more strongly to survival and severity of left ventricular systolic dysfunction, suggesting that for physicians the NYHA classification may have become a “heart failure severity score” and not as was intended, purely a measure of a patient's symptoms and functional status.
Key Words: Heart failure, Prognosis, Symptom score
To access this article, please choose from the options below
Dr Cleland has received grants and speakers' honoraria from Roche Diagnostics related to the clinical use of natriuretic peptides. Dr Goode has received travel and accommodation grants for conference presentation from Roche Diagnostics. Drs Clark and Nabb have no conflicts of interest.
PII: S1071-9164(08)00042-0
doi:10.1016/j.cardfail.2008.01.014
© 2008 Elsevier Inc. All rights reserved.
